Nalaganje...

Ten years of non-vitamin K antagonists oral anticoagulants for stroke prevention in atrial fibrillation: is warfarin obsolete?

Currently, four non-vitamin K antagonists oral anticoagulants (NOACs) are available for stroke prevention in atrial fibrillation (AF). These have been in clinical use for up to 10 years now. Besides data of the initial phase III clinical trials, now clinical data, several sub-studies, meta-analyses,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur Heart J Suppl
Main Authors: Hammwöhner, Matthias, Goette, Andreas
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7753780/
https://ncbi.nlm.nih.gov/pubmed/33380942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/suaa177
Oznake: Označite
Brez oznak, prvi označite!